Growth Metrics

Enanta Pharmaceuticals (ENTA) EPS (Basic) Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 36.89%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36.89%
Dec 31, 2025 32.90%
Sep 30, 2025 11.51%
Jun 30, 2025 17.79%
Mar 31, 2025 13.36%
Dec 31, 2024 10.81%
Sep 30, 2024 -3.69%
Jun 30, 2024 3.48%
Mar 31, 2024 -10.48%
Dec 31, 2023 -56.78%
Sep 30, 2023 3.06%
Jun 30, 2023 -37.85%
Mar 31, 2023 -81.37%
Dec 31, 2022 -59.32%
Sep 30, 2022 -67.53%
Jun 30, 2022 -84.20%
Mar 31, 2022 -113.72%
Dec 31, 2021 -45.88%
Sep 30, 2021 -42.03%
Jun 30, 2021 -46.33%
Mar 31, 2021 -54.35%
Dec 31, 2020 -38.77%
Sep 30, 2020 -40.35%
Jun 30, 2020 -17.29%
Mar 31, 2020 -2.33%
Dec 31, 2019 66.50%
Sep 30, 2019 93.30%
Jun 30, 2019 100.00%
Mar 31, 2019 63.03%
Dec 31, 2018 -1.21%
Sep 30, 2018 67.51%
Jun 30, 2018 100.64%
Mar 31, 2018 -24.99%
Dec 31, 2017 -35.37%
Sep 30, 2017 108.58%
Jun 30, 2017 -29.33%
Mar 31, 2017 0.00%
Dec 31, 2016 4.66%
Sep 30, 2016 28.86%
Jun 30, 2016 36.10%
Mar 31, 2016 65.95%
Dec 31, 2015 -4.78%
Sep 30, 2015 27.30%
Jun 30, 2015 26.62%
Mar 31, 2015 -13.87%